PROTO SCRIPT PHARMACEUTICAL CORP Net Cash Provided by (Used in) Investing Activities, Continuing Operations
PROTO SCRIPT PHARMACEUTICAL CORP reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$21.62 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2018-03-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-03-08
- PROTO SCRIPT PHARMACEUTICAL CORP net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$600.00.
- PROTO SCRIPT PHARMACEUTICAL CORP net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$11.64K.
- PROTO SCRIPT PHARMACEUTICAL CORP net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$9.38K.
- PROTO SCRIPT PHARMACEUTICAL CORP net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$12.23K.
- PROTO SCRIPT PHARMACEUTICAL CORP net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$15.23K.
- PROTO SCRIPT PHARMACEUTICAL CORP net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$6.06K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-09-30 | -$600.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-08 | -$12.24K derived: sum of 2 quarters · filed 2018-03-08 | -$21.62K 10-Q · filed 2018-03-08 | -$33.85K derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-06-30 | -$11.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-17 | -$21.02K 10-Q · filed 2018-01-17 | -$33.25K derived: sum of 3 quarters · filed 2018-01-17 | |
| 2017-03-31 | -$9.38K 10-Q · filed 2017-11-22 | -$21.60K derived: sum of 2 quarters · filed 2017-11-22 | ||
| 2016-12-31 | -$12.23K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-10-19 | -$15.23K 10-K/A · filed 2017-10-19 | ||
| 2016-09-30 | -$3.00K 10-Q · filed 2018-03-08 | |||
| 2015-12-31 | -$6.06K 10-K/A · filed 2017-10-19 |